Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Head Neck ; 38(4): 499-505, 2016 Apr.
Article in English | MEDLINE | ID: mdl-25445257

ABSTRACT

BACKGROUND: We sought to validate the consensus recommendation and assess dosimetric significance of selective omission of nodal level V from intensity-modulated radiotherapy (IMRT) clinical target volume (CTV) for oropharyngeal cancer. METHODS: IMRT plans and clinical outcomes for 112 patients with oropharyngeal cancer (nodal classification N0-N2b) were analyzed for coverage of ipsilateral and contralateral nodal level V. Additionally, new IMRT plans were generated in 6 randomly selected patients to assess its dosimetric impact. RESULTS: With median follow-up of 3.4 years, there were no failures identified in nodal level V with or without nodal level V omission. Upon dosimetric evaluation, significant reduction in integral dose, V10 Gy , V20 Gy , V30 Gy , V40 Gy , and V50 Gy was observed by excluding unilateral and bilateral level V from the CTV. CONCLUSION: We clinically validate the consensus recommendation for selective omission of level V nodal coverage in IMRT planning of patients with oropharyngeal cancer and demonstrate significant dosimetric advantages.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Head and Neck Neoplasms/radiotherapy , Lymph Nodes/radiation effects , Oropharyngeal Neoplasms/radiotherapy , Radiotherapy, Intensity-Modulated/methods , Adult , Aged , Carcinoma, Squamous Cell/secondary , Female , Follow-Up Studies , Head and Neck Neoplasms/secondary , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Recurrence, Local , Oropharyngeal Neoplasms/pathology , Radiometry , Radiotherapy Dosage , Squamous Cell Carcinoma of Head and Neck , Survival Analysis , Treatment Outcome
2.
Technol Cancer Res Treat ; 14(3): 315-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25782188

ABSTRACT

There is considerable practice variation in treatment of the node negative (N0) contralateral neck in patients with head and neck cancer. In this study, we examined the impact of N0 neck target delineation volume on radiation dose to the contralateral parotid gland. Following institutional review board approval, 12 patients with head and neck cancer were studied. All had indications for treatment of the N0 neck, such as midline base of tongue or soft palate extension or advanced ipsilateral nodal disease. The N0 neck volumes were created using the Radiation Therapy Oncology Group head and neck contouring atlas. The physician-drawn N0 neck clinical target volume (CTV) was expanded by 25% to 200% to generate volume variation, followed by a 3-mm planning target volume (PTV) expansion. Surrounding organs at risk were contoured and complete intensity-modulated radiation therapy plans were generated for each N0 volume expansion. The median N0 target volume drawn by the radiation oncologist measured 93 cm(3) (range 71-145). Volumetric expansion of the N0 CTV by 25% to 200% increased the resultant mean dose to the contralateral parotid gland by 1.4 to 8.5 Gray (Gy). For example, a 4.1-mm increase in the N0 neck CTV translated to a 2.0-Gy dose increase to the parotid, 7.4 mm to a 4.5 Gy dose increase, and 12.5 mm to an 8.5 Gy dose increase, respectively. The treatment volume designated for the N0 neck has profound impact on resultant dose to the contralateral parotid gland. Variations of up to 15 mm are routine across physicians in target contouring, reflecting individual preference and training expertise. Depending on the availability of immobilization and image guidance techniques, experts commonly recommend 3 to 10 mm margin expansions to generate the PTV. Careful attention to the original volume of the N0 neck CTV, as well as expansion margins, is important in achieving effective contralateral gland sparing to reduce the resultant xerostomia and dysguesia that may ensue after radiotherapy.


Subject(s)
Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/radiotherapy , Lymph Nodes/pathology , Neck/diagnostic imaging , Neck/pathology , Parotid Gland/diagnostic imaging , Humans , Parotid Gland/pathology , Radiography , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Conformal/methods
3.
IEEE Trans Biomed Eng ; 59(1): 255-62, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22010142

ABSTRACT

We have developed an inexpensive PC camera-based system to measure sensor position and to track head motion during magnetoencephalography recordings. The system employs mirrors to triangulate the position of markers using a single camera. Sensor position measurement and head tracking can be performed without the need to manually digitize markers or fiducial points. The system is capable of measuring relative 3-D position within the required volume of interest with an accuracy of ~450 µm and can be constructed for approximately $150.


Subject(s)
Artifacts , Brain Mapping/methods , Head Movements/physiology , Imaging, Three-Dimensional/instrumentation , Magnetoencephalography/instrumentation , Optical Devices , Prenatal Diagnosis/instrumentation , Equipment Design , Equipment Failure Analysis , Humans , Reproducibility of Results , Sensitivity and Specificity , Transducers
SELECTION OF CITATIONS
SEARCH DETAIL
...